Arena Pharmaceuticals Inc
ARNADelisted Mar 11, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001080709
Arena Pharmaceuticals Inc was delisted on Mar 11, 2022; its insiders filed their last Form 4 on Mar 11, 2022; 317 institutions reported holding it in 13F filings for Q4 2021, worth $4.87B in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Arena Pharmaceuticals Inc as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
ARNA is no longer listed, and 13F filings after Q4 2021 list far fewer holders. See Q4 2021
- Institutional holders
- 1
- 0 vs. Q3 2022
- Shares held
- 1
- 0 (0.0%) vs. Q3 2022
- Total value
- $100
- +$100 vs. Q3 2022
- New holders
- 0
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $100 |
| Q1 2026 | 1 | $100 |
| Q4 2025 | 1 | $100 |
| Q3 2025 | 1 | $100 |
| Q2 2025 | 1 | $100 |
| Q1 2025 | 1 | $100 |
| Q4 2024 | 1 | $100 |
| Q3 2024 | 1 | $100 |
| Q2 2024 | 1 | $100 |
| Q1 2024 | 1 | $100 |
| Q4 2023 | 1 | $100 |
| Q3 2023 | 1 | $100 |
| Q2 2023 | 1 | $100 |
| Q1 2023 | 1 | $100 |
| Q4 2022 | 1 | $100 |
| Q3 2022 | 1 | $0 |
| Q2 2022 | 1 | $0 |
| Q1 2022 | 2 | $1.00K |
| Q4 2021 | 317 | $4.87B |
| Q3 2021 | 236 | $3.35B |
| Q2 2021 | 236 | $3.87B |
| Q1 2021 | 234 | $3.89B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Arena Pharmaceuticals Inc; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Huntington National Bank | 1 | $100 | 0.00% | 00.0% | Unchanged |